oral
squamou
cell
carcinoma
oscc
tumor
oral
caviti
epitheli
origin
affect
peopl
per
year
worldwid
mortal
rate
improv
decad
year
surviv
rate
tumor
microenviron
compris
cancer
cell
variou
normal
cell
includ
immun
inflammatori
stromal
sever
studi
indic
macrophag
infiltr
tumor
microenviron
promot
tumor
immunosuppress
cancer
progress
angiogenesi
invas
metastasi
phenotyp
macrophag
call
tumorassoci
macrophag
significantli
associ
poor
prognosi
ptnm
stage
lymph
node
metastasi
lung
thu
consid
use
marker
activ
tam
hemoglobin
scaveng
receptor
specif
express
monocytemacrophag
system
recent
found
solubl
also
may
potenti
diagnost
paramet
monitor
activ
macrophag
inflammatori
class
scaveng
receptor
involv
pathogenesi
atherosclerosi
pattern
recognit
pathogen
macrophag
mannos
receptor
strongli
express
prostat
adenocarcinoma
number
tam
correl
poor
prognosi
tam
secret
extens
amount
proangiogen
growth
factor
includ
epiderm
growth
factor
egf
consid
potent
sourc
egf
tumor
egf
act
chemotact
factor
tumor
microenviron
promot
motil
invas
tumor
cell
consequ
acceler
egf
also
shown
promot
cancer
cell
prolifer
cultur
breast
cancer
studi
investig
express
tam
oscc
associ
clinic
outcom
also
examin
level
egf
product
tam
subset
effect
prolifer
oscc
cell
institut
review
board
center
clinic
translat
research
kyushu
univers
hospit
irb
serial
number
author
studi
design
method
studi
perform
along
permit
guidelin
written
inform
consent
obtain
patient
andor
legal
guardian
admiss
accordingli
involv
studi
fortyfour
enrol
patient
primari
oscc
treat
depart
oral
maxillofaci
surgeri
kyushu
univers
hospit
mean
age
year
rang
year
male
femal
patient
take
biopsi
sampl
buffer
formalin
solut
use
fix
specimen
implant
paraffin
make
block
thick
section
prepar
paraffinembed
specimen
hematoxylin
eosin
h
e
use
stain
section
confirm
diagnosi
histolog
grade
profession
oral
pathologist
stage
tumor
classifi
state
tnm
classif
intern
union
cancer
classif
use
determin
tumor
histolog
grade
accord
yamamotokohama
clinic
classif
oscc
pattern
tumor
invas
assess
h
estain
specimen
grade
welldefin
borderlin
grade
cord
lessmark
borderlin
grade
group
cell
distinct
borderlin
grade
diffus
invas
cordlik
type
invas
widespread
type
invas
patient
type
clinicopatholog
characterist
tumor
shown
tabl
first
deparaffin
section
xylen
hydrat
grade
seri
ethanol
detail
stain
procedur
mention
previou
follow
primari
antibodi
use
incub
section
overnight
primari
antibodi
includ
rabbit
clone
abcam
tokyo
japan
dilut
rabbit
clone
abcam
tokyo
japan
dilut
mous
clone
novocastra
newcastl
uk
dilut
mous
clone
transgen
inc
kumamoto
japan
dilut
mous
clone
abnova
taipei
taiwan
dilut
rabbit
antiegf
clone
abcam
tokyo
japan
dilut
antibodi
wash
tbst
chromogen
dab
peroxidas
stain
dab
kit
nacalai
tesqu
kyoto
japan
appli
section
final
mayer
hemalum
solut
merck
kgaa
darmstadt
germani
dilut
use
counterstain
section
wash
two
time
min
dehydr
section
mount
coverslip
number
egfposit
cell
count
section
five
independ
highpow
microscop
field
slide
microwav
buffer
color
manual
ihc
kit
perkinelm
waltham
usa
cool
min
section
incub
antibodi
diluentblock
buffer
color
manual
ihc
kit
perkinelm
min
room
temperatur
incub
primari
antibodi
list
doubl
stain
perform
tripl
stain
perform
h
room
temperatur
sampl
wash
three
time
tbst
min
incub
polym
hrp
ms
rb
color
manual
ihc
kit
perkinelm
sampl
rins
three
time
tbst
min
incub
opal
fluorosphor
work
solut
color
manual
ihc
kit
perkinelm
min
room
temperatur
sampl
rins
tbst
microwav
buffer
mount
vectashield
mount
medium
fluoresc
dapi
vector
laboratori
burlingam
ca
usa
doubl
stain
label
opal
fluorosphor
green
egf
label
opal
fluorosphor
red
tripl
stain
label
opal
fluorosphor
green
opal
fluorosphor
red
opal
fluorosphor
white
respect
take
photomicrograph
use
light
microscop
digit
camera
seri
keyenc
tokyo
japan
ratio
egfposit
cell
immun
cell
defin
ratio
number
egf
immun
cell
yellow
whole
number
immun
cell
yellow
green
field
view
five
separ
area
detect
intracellular
egf
oscc
patient
peripher
blood
mononuclear
cell
pbmc
cellsml
collect
cultur
pb
stimul
ngml
pma
phorbol
wako
tokyo
japan
ionomycin
ionomycin
calcium
wako
brefeldin
solut
biolegend
san
diego
ca
usa
dilut
h
moisten
chamber
suppli
next
harvest
cell
wash
ebiosci
flow
cytometri
stain
buffer
thermo
fisher
scientif
waltham
usa
rins
cell
incub
normal
temperatur
min
dark
pe
antihuman
antibodi
clone
biolegend
fitc
antihuman
antibodi
clone
miltenyi
biotec
bergisch
gladbach
germani
antihuman
antibodi
clone
biolegend
use
pe
mous
biolegend
fitc
rea
control
viobright
antibodi
recombin
human
miltenyi
biotec
mous
biolegend
isotyp
control
antibodi
cell
fix
permeabil
fixat
buffer
biolegend
intercellular
stain
perm
wash
buffer
biolegend
follow
stain
apc
antihhb
egf
clone
r
system
minneapoli
mn
usa
apc
mous
r
system
serv
neg
control
use
bd
flow
cytomet
franklin
lake
new
jersey
unit
state
bd
softwar
acquir
analyz
fac
data
pbmc
healthi
donor
collect
use
easyseptm
human
monocyt
isol
kit
stemcel
technolog
inc
vancouv
canada
monocyt
isol
isol
cell
cellsml
differenti
macrophag
cellxvivo
human
macrophag
differenti
kit
r
system
humidifi
chamber
atmospher
day
differenti
macrophag
collect
wash
count
cell
transfer
three
ml
tube
right
cell
incub
fitc
antihuman
antibodi
biolegend
fitc
antihuman
antibodi
miltenyi
biotec
fitc
antihuman
antibodi
biolegend
min
dark
mac
buffer
miltenyi
biotec
use
rins
sampl
incub
antifitc
microbead
miltenyi
biotec
min
subsequ
sampl
wash
sort
three
differ
follow
tam
subset
cell
manual
magneticactiv
cell
sort
procedur
minimacstm
separ
start
kit
miltenyi
biotec
state
manufactur
instruct
manual
earlier
tam
subset
cellsml
cultur
dulbecco
modifi
eagl
medium
nutrient
mixtur
life
technolog
corpor
carlsbad
ca
usa
fb
sigmaaldrich
st
loui
mo
usa
penicillinstreptomycin
mix
solut
nacalai
tesqu
kyoto
japan
everi
day
cultur
collect
condit
medium
cm
tam
subset
store
cm
use
cm
cell
sampl
dmem
life
technolog
corpor
fb
sigmaaldrich
control
elisa
concentr
cm
use
merck
millipor
burlington
usa
total
ml
cultur
medium
centrifug
min
make
sampl
sampl
examin
use
human
egf
quantikin
elisa
kit
r
system
minneapoli
mn
usa
accord
manufactur
guidelin
egf
concentr
measur
use
multiskan
fc
micropl
reader
thermo
fisher
scientif
waltham
usa
wavelength
nm
oscc
cell
line
squua
squub
use
studi
establish
cell
line
done
metastat
cervic
lymph
node
lesion
oscc
floor
squua
squub
cell
line
establish
recurr
tongu
cancer
patient
orthotop
cell
stain
cfse
cell
divis
assay
kit
cayman
chemic
compani
ann
arbor
mi
usa
report
manufactur
instruct
cultur
dmem
life
technolog
corpor
fb
sigmaaldrich
variou
day
cell
divis
analyz
use
bd
flow
cytomet
cell
cultur
dish
cm
cell
day
without
antiegfr
antibodi
clone
abcam
tokyo
japan
dilut
dmem
life
technolog
corpor
fb
sigmaaldrich
use
control
cell
prolifer
examin
xtt
cell
prolifer
assay
kit
cayman
chemic
compani
ann
arbor
mi
usa
mention
manufactur
color
absorb
sampl
read
use
multiskan
fc
micropl
reader
thermo
fisher
scientif
waltham
usa
wavelength
nm
cell
line
cultur
day
cm
cell
use
invas
assay
use
invas
chamber
corn
incorpor
corn
ny
usa
follow
product
guidelin
three
matrigel
three
control
insert
prepar
well
cultur
dish
cm
tam
use
chemoattract
well
subsequ
insert
fill
dmem
life
technolog
corpor
without
serum
cell
line
cellsinsert
cell
cultur
hour
humid
chamber
atmospher
state
temp
insert
remov
well
matrigel
clean
cell
fix
methanol
junsei
chemic
co
ltd
tokyo
japan
stain
mayer
hemalum
solut
merck
kgaa
darmstadt
germani
dilut
tissuetek
eosin
sakura
finetek
japan
co
ltd
tokyo
japan
supplementari
method
number
cell
membran
count
section
five
differ
highpow
microscop
field
averag
number
cell
matrigel
insert
membran
divid
averag
number
cell
control
insert
membran
multipli
calcul
invas
percentag
jmp
softwar
version
sa
institut
nc
usa
use
carri
statist
analys
signific
differ
group
assess
u
test
kruskalw
test
wilcoxon
test
spearman
rank
correl
coeffici
test
progressionfre
surviv
pf
diseasespecif
surviv
dss
evalu
kaplanmei
method
use
use
cox
hazard
test
curv
comparison
calcul
receiv
oper
characterist
roc
curv
use
evalu
sensit
specif
area
curv
auc
analys
p
valu
consid
statist
signific
immunohistochem
stain
perform
evalu
local
tam
marker
oscc
tissu
repres
histolog
result
shown
fig
express
diffus
detect
tumor
stroma
around
tumor
express
mainli
detect
around
tumor
fig
tripl
immunofluoresc
stain
confirm
distribut
tam
marker
oscc
tissu
quit
differ
fig
immunohistochem
stain
show
express
egf
proangiogen
growth
factor
strongli
detect
throughout
tumor
epitheli
cell
fig
clarifi
whether
tam
subset
express
egf
doubl
immunofluoresc
stain
tam
marker
egf
perform
shown
fig
three
tam
marker
partial
coloc
egf
moreov
lymphocyt
cell
also
partial
coloc
egf
egf
mainli
express
tam
especi
tam
suppl
fig
determin
whether
cell
express
egf
isol
three
tam
subset
pbmc
patient
oscc
examin
express
level
egf
shown
fig
b
cell
express
higher
level
number
egf
intracellularli
compar
cell
result
suggest
differ
express
egf
among
tam
subset
determin
product
egf
tam
subset
also
evalu
concentr
egf
cm
tam
subset
concentr
egf
cm
cell
higher
cell
fig
next
examin
effect
cocultur
cm
tam
subset
cell
oscc
cell
vitro
fig
first
evalu
cell
divis
rate
three
oscc
cell
line
includ
squua
squub
found
cell
show
high
cell
divis
rate
compar
squua
squub
cell
suppl
fig
therefor
select
cell
subsequ
cocultur
experi
cell
prolifer
assay
reveal
highli
increas
viabil
cell
cocultur
cm
cell
comparison
cell
cocultur
cell
cm
furthermor
found
antiegfr
antibodi
significantli
reduc
viabil
cell
cocultur
cm
tam
subset
especi
cell
fig
also
confirm
effect
egfr
express
cell
cocultur
tam
subset
cm
signific
differ
among
tam
subset
suppl
fig
similar
result
observ
invas
assay
invas
activ
cell
cocultur
cm
cell
enhanc
invas
cell
cocultur
cell
cm
fig
next
examin
associ
tam
subset
clinicopatholog
factor
oscc
patient
number
tam
subset
count
singl
stain
shown
tabl
number
cell
show
signific
associ
clinicopatholog
find
howev
oscc
patient
clinic
stage
clinic
classif
cervic
nodal
metastasi
show
signific
increas
number
cell
evalu
correl
tam
subset
clinic
prognosi
oscc
patient
surviv
rate
estim
use
kaplanmei
method
divid
oscc
patient
low
high
express
group
accord
mean
number
tam
subset
pf
dd
signific
differ
low
high
express
howev
patient
high
express
significantli
unfavor
outcom
low
express
group
fig
accord
result
specul
potenti
indic
describ
malign
oscc
perform
statist
analysi
roc
curv
clinic
prognosi
auc
area
dfsrelat
roc
curv
express
respect
dssrelat
roc
curv
express
respect
fig
result
indic
higher
sensit
specif
express
advers
prognosi
moreov
univari
analysi
reveal
pf
dss
associ
yk
criteria
number
cell
tabl
togeth
result
suggest
cell
play
key
role
invas
metastasi
oscc
metchnikov
et
al
first
demonstr
macrophag
effici
phagocyt
play
major
role
inflamm
natur
cellular
macrophag
consid
notabl
effector
cell
function
cytotox
kill
tumor
macrophag
divid
two
function
distinct
subtyp
classic
activ
macrophag
stimul
helper
type
respons
altern
activ
macrophag
stimul
macrophag
produc
proinflammatori
cytokin
contribut
tumor
suppress
wherea
macrophag
express
antiinflammatori
cytokin
shown
contribut
tumor
promot
angiogenesi
immunosuppress
activ
tumor
recent
studi
describ
macrophag
tam
highli
express
marker
includ
member
scaveng
receptor
cysteinerich
famili
class
b
mainli
express
matur
tissu
main
function
bind
hemoglobinhaptoglobin
complex
addit
macrophag
infiltr
inflammatori
tissu
involv
resolut
prototyp
member
famili
structur
differ
transmembran
receptor
conjointli
term
scaveng
receptor
primarili
express
macrophag
dendrit
recogn
modifi
lipid
protein
exogen
pathogenassoci
molecular
pattern
apoptot
cell
previous
report
promot
tcell
apoptosi
immunosuppress
via
program
deathligand
oscc
contribut
lipid
metabol
atherogenesi
metabol
ctype
lectin
altern
term
macrophag
mannos
receptor
gener
express
tissu
macrophag
dendrit
cell
specif
lymphat
endotheli
cell
play
import
role
immun
homeostasi
high
express
increasingli
detect
tumor
tam
play
import
function
tumor
microenviron
role
invas
prolifer
sever
studi
indic
tam
secret
variou
kind
cytokin
includ
growth
factor
exampl
egf
egf
strongli
induc
tumor
cell
present
studi
examin
express
tam
subset
oscc
tissu
relationship
express
tam
marker
egf
product
tumor
progress
immunohistochem
stain
demonstr
mark
differ
local
cell
oscc
tissu
interestingli
cell
pbmc
oscc
patient
strongli
produc
egf
compar
tam
subset
addit
oscc
cell
show
high
viabil
invas
activ
cocultur
cm
cell
signific
decreas
viabil
antiegfr
antibodi
result
suggest
tam
might
play
import
role
prolifer
invas
oscc
via
egf
secret
goswami
et
found
paracrin
loop
breast
carcinoma
cell
macrophag
egf
coloni
stimul
factor
product
lead
increas
carcinoma
cell
invas
paracrin
loop
might
also
involv
invas
activ
oscc
cell
examin
need
clarifi
express
cytokin
secret
tam
subset
oscc
next
examin
involv
tam
prognosi
oscc
patient
number
tam
oscc
posit
correl
sever
clinicopatholog
factor
includ
clinic
stage
clinic
classif
mode
invas
cervic
nodal
metastasi
notabl
high
number
tam
significantli
correl
poor
prognosi
recent
dong
et
report
high
presenc
tam
hepatocellular
carcinoma
markedli
correl
aggress
tumor
phenotyp
associ
poor
prognosi
result
consist
result
contrast
adult
tcell
leukemialymphoma
tam
associ
clinic
controversi
result
may
due
differ
tumor
type
conclus
demonstr
tam
promot
prolifer
invas
oscc
cell
via
egf
high
number
tam
predict
unfavor
clinic
prognosi
oscc
patient
howev
still
necessari
elucid
involv
cytokin
secret
tam
tumorigenesi
detail
knowledg
role
tam
subset
could
lead
develop
novel
pharmacolog
approach
target
tam
product
inhibit
tumor
progress
metastasi
